FAU in Treating Patients With Advanced Solid Tumors or Lymphoma
NCT00769288 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2014-01-07
Summary
Drugs used in chemotherapy, such as FAU, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. This phase I trial is studying the side effects and best dose of FAU in treating patients with advanced solid tumors or lymphoma.
Conditions
- Adult Grade III Lymphomatoid Granulomatosis
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- Anaplastic Large Cell Lymphoma
- Angioimmunoblastic T-cell Lymphoma
- Cutaneous B-cell Non-Hodgkin Lymphoma
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- Nodal Marginal Zone B-cell Lymphoma
- Recurrent Adult Burkitt Lymphoma
- Recurrent Adult Diffuse Large Cell Lymphoma
- Recurrent Adult Diffuse Mixed Cell Lymphoma
- Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
- Recurrent Adult Grade III Lymphomatoid Granulomatosis
- Recurrent Adult Hodgkin Lymphoma
- Recurrent Adult Immunoblastic Large Cell Lymphoma
- Recurrent Adult Lymphoblastic Lymphoma
- Recurrent Adult T-cell Leukemia/Lymphoma
- Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
- Recurrent Grade 1 Follicular Lymphoma
- Recurrent Grade 2 Follicular Lymphoma
- Recurrent Grade 3 Follicular Lymphoma
- Recurrent Mantle Cell Lymphoma
- Recurrent Marginal Zone Lymphoma
- Recurrent Mycosis Fungoides/Sezary Syndrome
- Recurrent Small Lymphocytic Lymphoma
- Small Intestine Lymphoma
- Splenic Marginal Zone Lymphoma
- Stage III Adult Burkitt Lymphoma
- Stage III Adult Diffuse Large Cell Lymphoma
- Stage III Adult Diffuse Mixed Cell Lymphoma
- Stage III Adult Diffuse Small Cleaved Cell Lymphoma
- Stage III Adult Hodgkin Lymphoma
- Stage III Adult Immunoblastic Large Cell Lymphoma
- Stage III Adult Lymphoblastic Lymphoma
- Stage III Adult T-cell Leukemia/Lymphoma
- Stage III Cutaneous T-cell Non-Hodgkin Lymphoma
- Stage III Grade 1 Follicular Lymphoma
- Stage III Grade 2 Follicular Lymphoma
- Stage III Grade 3 Follicular Lymphoma
- Stage III Mantle Cell Lymphoma
- Stage III Marginal Zone Lymphoma
- Stage III Mycosis Fungoides/Sezary Syndrome
- Stage III Small Lymphocytic Lymphoma
- Stage IV Adult Burkitt Lymphoma
- Stage IV Adult Diffuse Large Cell Lymphoma
- Stage IV Adult Diffuse Mixed Cell Lymphoma
- Stage IV Adult Diffuse Small Cleaved Cell Lymphoma
- Stage IV Adult Hodgkin Lymphoma
- Stage IV Adult Immunoblastic Large Cell Lymphoma
- Stage IV Adult Lymphoblastic Lymphoma
- Stage IV Adult T-cell Leukemia/Lymphoma
- Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma
- Stage IV Grade 1 Follicular Lymphoma
- Stage IV Grade 2 Follicular Lymphoma
- Stage IV Grade 3 Follicular Lymphoma
- Stage IV Mantle Cell Lymphoma
- Stage IV Marginal Zone Lymphoma
- Stage IV Mycosis Fungoides/Sezary Syndrome
- Stage IV Small Lymphocytic Lymphoma
- Unspecified Adult Solid Tumor, Protocol Specific
- Waldenström Macroglobulinemia
Interventions
- DRUG
-
2'-F-ara-deoxyuridine
Given IV
- OTHER
-
positron emission tomography
Correlative studies
- OTHER
-
laboratory biomarker analysis
Correlative studies
- OTHER
-
pharmacological study
Correlative studies
- OTHER
-
pharmacogenomic studies
Correlative studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Patricia LoRusso · Wayne State University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2013-12-31
Countries
- United States
Study Locations
More Related Trials
-
Study of 124I-NM404 in Advanced Solid Malignancies
NCT01662284 ·Status: TERMINATED
-
Safety, Tolerability, Immunogenicity and Pharmacokinetics of ONC-841
NCT06219499 ·Status: WITHDRAWN ·Phase: PHASE1
-
Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer
NCT01673711 ·Status: COMPLETED
-
UCN-01 in Treating Patients With Advanced Cancer
NCT00003289 ·Status: COMPLETED ·Phase: PHASE1
-
Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
NCT04862585 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
MTD Determination, Safety and Efficacy of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer
NCT01628471 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies
NCT00038025 ·Status: COMPLETED ·Phase: PHASE2
-
AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery
NCT00348699 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms
NCT00001444 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer
NCT00141297 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients
NCT00851448 ·Status: TERMINATED ·Phase: NA
-
Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer
NCT00019656 ·Status: COMPLETED ·Phase: PHASE1
-
Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease
NCT01125449 ·Status: WITHDRAWN ·Phase: PHASE2
-
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
NCT01958372 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors
NCT03057366 ·Status: COMPLETED ·Phase: PHASE1
-
Deuteporfin Tolerance and Pharmacokinetics in Healthy Volunteers
NCT01481597 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
NCT05183126 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors
NCT00570284 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Orally Administered CUDC-101 in Cancer Patients
NCT01702285 ·Status: TERMINATED ·Phase: PHASE1
-
Studying Fentanyl in Patients With Cancer
NCT00899951 ·Status: TERMINATED
-
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
NCT01849250 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Food Effect on the Pharmacokinetics of Fuzuloparib Capsules in Chinese Healthy Adult Subjects
NCT05440006 ·Status: COMPLETED ·Phase: PHASE1
-
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer
NCT06855524 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Assess Mass Balance, Pharmacokinetics (PK), and Metabolism of Orally Administered [14 C]-TAK-659 in Participants With Advanced Solid Tumor and/or Lymphoma Malignancies
NCT03338881 ·Status: WITHDRAWN ·Phase: PHASE1
-
Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma
NCT00002909 ·Status: COMPLETED ·Phase: PHASE1